Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12576087 | Aryloxypiperidine pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors | 🖼🧊📄§ | 2026-03-17 | 2039-08-16 | 0 | 31 |
| 12576088 | Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B | 🖼🧊📄§ | 2026-03-17 | 2043-09-15 | 0 | 31 |
| 12576089 | Platelet count-agnostic methods of treating myelofibrosis | 🖼🧊📄§ | 2026-03-17 | 2044-03-12 | 0 | 31 |
| 12576084 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-17 | 2045-01-31 | 0 | 31 |
| 12576082 | METTL16 inhibitors and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-08-20 | 0 | 31 |
| 12576080 | Use of varenicline for treating ocular conditions | 🖼🧊📄§ | 2026-03-17 | 2045-04-03 | 0 | 31 |
| 12576076 | Use of HSP70 as a regulator of enzymatic activity | 🖼🧊📄§ | 2026-03-17 | 2044-02-19 | 0 | 31 |
| 12576078 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 🖼🧊📄§ | 2026-03-17 | 2045-04-17 | 0 | 31 |
| 12576014 | Personal care composition with visually distinct aqueous and oil phase | 🖼🧊📄§ | 2026-03-17 | 2041-04-20 | 0 | 31 |
| 12576016 | Composition containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a preservative and/or antioxidant, a surfactant and a polymer, and the method for processing keratin materials from the composition | 🖼🧊📄§ | 2026-03-17 | 2040-12-02 | 0 | 31 |
| 12576012 | Surface-modified zinc oxide particles, dispersion solution, and cosmetic | 🖼🧊📄§ | 2026-03-17 | 2040-04-30 | 0 | 31 |
| 12576020 | Increasing the stability of agents for the treatment of keratinous material | 🖼🧊📄§ | 2026-03-17 | 2040-02-05 | 0 | 31 |
| 12576021 | Method of making and using a skin moisturizing formulation | 🖼🧊📄§ | 2026-03-17 | 2041-06-18 | 0 | 31 |
| 12576019 | Personal cleansing composition with an organic acid having a pKa greater than 2.7 | 🖼🧊📄§ | 2026-03-17 | 2042-10-28 | 0 | 31 |
| 12576018 | Active agents for skin and hair care with sensory modifying properties | 🖼🧊📄§ | 2026-03-17 | 2039-02-04 | 0 | 31 |
| 12576026 | Formulations of nebivolol | 🖼🧊📄§ | 2026-03-17 | 2041-07-08 | 0 | 31 |
| 12576028 | Pharmaceutical or nutraceutical self-emulsifying solid dispersion composition | 🖼🧊📄§ | 2026-03-17 | 2043-01-18 | 0 | 31 |
| 12576029 | Noncompetitive receptor-targeted vaccine delivery to plasmacytoid dendritic cells | 🖼🧊📄§ | 2026-03-17 | 2043-07-12 | 0 | 31 |
| 12576025 | Pharmaceutical parenteral composition of dual GLP1/2 agonist | 🖼🧊📄§ | 2026-03-17 | 2040-06-12 | 0 | 31 |
| 12576027 | Diclofenac topical formulation with a high absorption rate | 🖼🧊📄§ | 2026-03-17 | 2042-06-22 | 0 | 31 |
| 12576034 | Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione | 🖼🧊📄§ | 2026-03-17 | 2040-05-14 | 0 | 31 |
| 12576035 | Polymeric implants with high drug loading and long-acting drug release and methods of making the same | 🖼🧊📄§ | 2026-03-17 | 2040-01-31 | 0 | 31 |
| 12576032 | Liquid clonidine extended release composition | 🖼🧊📄§ | 2026-03-17 | 2044-01-23 | 0 | 31 |
| 12576039 | Lipid-polymer compositions and methods of use | 🖼🧊📄§ | 2026-03-17 | 2041-05-18 | 0 | 31 |
| 12576038 | Composition, lipid particle manufacturing kit, substance delivery method, and detection method | 🖼🧊📄§ | 2026-03-17 | 2041-09-10 | 0 | 31 |
| 12576044 | Treatment of Alzheimer's disease | 🖼🧊📄§ | 2026-03-17 | 2043-05-03 | 0 | 31 |
| 12576046 | Aqueous paediatric retinol formulations | 🖼🧊📄§ | 2026-03-17 | 2039-11-26 | 0 | 31 |
| 12576048 | Anti-cancer activity of adamantane derivatives | 🖼🧊📄§ | 2026-03-17 | 2039-12-05 | 0 | 31 |
| 12576047 | Telomerase activating compounds for use in fertility and related applications | 🖼🧊📄§ | 2026-03-17 | 2043-08-25 | 0 | 31 |
| 12576050 | Dosage regime | 🖼🧊📄§ | 2026-03-17 | 2039-10-17 | 0 | 31 |
| 12576051 | Methods and composition for treating respiratory obstructive diseases | 🖼🧊📄§ | 2026-03-17 | 2040-07-30 | 0 | 31 |
| 12576049 | Onychomycosis treatment methods | 🖼🧊📄§ | 2026-03-17 | 2042-04-04 | 0 | 31 |
| 12576055 | Disease detection and treatment based on trimethyl-lysine levels | 🖼🧊📄§ | 2026-03-17 | 2039-02-01 | 0 | 31 |
| 12576054 | Vigabatrin liquid pharmaceutical composition | 🖼🧊📄§ | 2026-03-17 | 2043-05-16 | 0 | 31 |
| 12576056 | Amino acid-containing granules | 🖼🧊📄§ | 2026-03-17 | 2040-09-18 | 0 | 31 |
| 12576059 | Methods and compositions for treatment of inflammatory disease | 🖼🧊📄§ | 2026-03-17 | 2044-03-21 | 0 | 31 |
| 12576061 | Agent for inducing regression of triglyceride deposit atherosclerosis | 🖼🧊📄§ | 2026-03-17 | 2041-03-05 | 0 | 31 |
| 12576060 | Water soluble 3-O-acetyl-11-keto-β-boswellic acid and metal ion compositions, process for their preparation and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2041-06-23 | 0 | 31 |
| 12576063 | Implantable drug delivery devices for localized drug delivery | 🖼🧊📄§ | 2026-03-17 | 2040-12-18 | 0 | 31 |
| 12576066 | Methods and compositions for treatment of mydriasis | 🖼🧊📄§ | 2026-03-17 | 2045-01-17 | 0 | 31 |
| 12576065 | Enhancing autophagy or increasing longevity by administration of urolithins | 🖼🧊📄§ | 2026-03-17 | 2045-04-04 | 0 | 31 |
| 12576064 | Urolithin gummy (pectin) formulations | 🖼🧊📄§ | 2026-03-17 | 2045-08-27 | 0 | 31 |
| 12576075 | Combination therapies for treating cancer | 🖼🧊📄§ | 2026-03-17 | 2039-10-30 | 0 | 31 |
| 12576071 | Pharmaceutical compositions | 🖼🧊📄§ | 2026-03-17 | 2044-12-02 | 0 | 31 |
| 12576072 | Liquid pharmaceutical composition | 🖼🧊📄§ | 2026-03-17 | 2041-12-03 | 0 | 31 |
| 12575549 | Application of TPK as a target in Alzheimer's disease | 🖼🧊📄§ | 2026-03-17 | 2042-02-02 | 0 | 31 |
| 12576086 | Aqueous composition, in particular for treating mucosa and/or wounds | 🖼🧊📄§ | 2026-03-17 | 2039-10-23 | 0 | 31 |
| 12576097 | Anti-tumor effective component of Hedyotis diffusa, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-04-02 | 0 | 31 |
| 12577297 | Anti-IL-23p19 antibody formulations | 🖼🧊📄§ | 2026-03-17 | 2040-09-08 | 0 | 31 |
| 12578343 | Selective ACKR3 modulators and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-04-30 | 0 | 31 |